Professor of Medicine, Mayo Medical School
Pulmonology
Dr. Michael J. Krowka, MD
|
|
Give Review
Doctor Michael J. Krowka, MD is an expert in the field of Pulmonology. He attended University of Nevada School of Medicine. University of Nevada School of Medicine is ranked 88 in research and 0 in primary care medicine He over the years received 1 awards: "America's Top Doctors". Dr. Michael J. Krowka is also a published physician. He has 94 paper published. The most recent paper is: Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. He accepts all Medicare patients.
Publications
- Inflammatory bowel diseases, Chronic liver diseases and the lung.
- Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.
- PortoPulmonary Hypertension: Formidable Dual Threat versus Hopeful Dual Therapy.
- The Impact of Left Ventricular Hypertrophy on Survival in Candidates for Liver Transplantation.
- Outcomes in liver transplant recipients for alpha-1 antitrypsin deficiency related cirrhosis.
- Pulmonary contraindications, indications and MELD exceptions for liver transplantation: A contemporary view and look forward.
- Survival benefits of liver transplant in severe hepatoPulmonary syndrome.
- Transthoracic echocardiography screening for the detection of portoPulmonary hypertension: A work in progress.
- HepatoPulmonary syndrome: Favorable outcomes in the MELD exception era.
- Management of Pulmonary complications in pretransplant patients.
- PortoPulmonary Hypertension: A Report From the US-Based REVEAL Registry.
- Prevalence of Spontaneous Portosystemic Shunts in Patients with PortoPulmonary Hypertension and Effect on Treatment.
- HepatoPulmonary Syndrome: Monitoring at Your Fingertip.
- Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival.
- Safety and efficacy of ambrisentan for the treatment of portoPulmonary hypertension.
- Health-related quality of life and survival in liver transplant candidates.
- Successful coil embolization of mediastinal bronchial artery aneurysm.
- Updated clinical classification of Pulmonary hypertension.
- Pulmonary hypertension is associated with reduced patient survival after kidney transplantation.
- Liver transplantation for Pulmonary vascular complications of pediatric end-stage liver disease.
- HepatoPulmonary syndrome--a liver-induced lung vascular disorder.
- Alpha1-antitrypsin deficiency carriers, tobacco smoke, Chronic obstructive pulmonary disease, and lung cancer risk.
- Screen for portoPulmonary hypertension, especially in liver transplant candidates.
- Pulmonary hypertension in patients with interstitial lung diseases.
- Model for end-stage liver disease (MELD) exception for hepatoPulmonary syndrome.
- Model for end-stage liver disease (MELD) exception for portoPulmonary hypertension.
- PortoPulmonary hypertension: Results from a 10-year screening algorithm.
- Evolving dilemmas and management of portoPulmonary hypertension.
- Bronchogenic cyst causing atrial fibrillation by impinging the right inferior Pulmonary vein.
- HepatoPulmonary syndrome and portoPulmonary hypertension: implications for liver transplantation.
- The impact of Pulmonary hypertension on survival in patients with idiopathic Pulmonary fibrosis.
- Pulmonary hypertension in patients with idiopathic Pulmonary fibrosis.
- PortoPulmonary hypertension and the issue of survival.
- Cardiovascular collapse induced by position-dependent Pulmonary vein occlusion in a patient with fibrosing mediastinitis.
- Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
- Many faces of portoPulmonary hypertension.
- Natural history of hepatoPulmonary syndrome: Impact of liver transplantation.
- The distinct concepts and implications of hepatoPulmonary syndrome and portoPulmonary hypertension.
- Echocardiographic and clinical characteristics of Pulmonary hypertension complicating Pulmonary Langerhans cell histiocytosis.
- Tracheal myxoma: a rare benign tracheal tumor.
- Diagnosis and differential assessment of Pulmonary arterial hypertension.
- Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment.
- HepatoPulmonary syndrome and portoPulmonary hypertension: a report of the multicenter liver transplant database.
- PortoPulmonary hypertension: diagnostic advances and caveats.
- Prospective evaluation of outcomes and predictors of mortality in patients with hepatoPulmonary syndrome undergoing liver transplantation.
- Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.
- Arterial oxygenation associated with portoPulmonary hypertension.
- Editorial: Pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from "primary" Pulmonary hypertension.
- Highlights of the ERS Task Force on Pulmonary-hepatic vascular disorders (PHD).
- Unexplained pulmonary hypertension in Chronic myeloproliferative disorders.
- HepatoPulmonary syndrome and extrahepatic vascular abnormalities.
- Caveats concerning hepatoPulmonary syndrome.
- HepatoPulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lu...
- HepatoPulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation.
- Accuracy of Doppler echocardiography in the assessment of Pulmonary hypertension in liver transplant candidates.
- Pulmonary hemodynamics and perioperative cardioPulmonary-related mortality in patients with portoPulmonary hypertension undergoing liver transplantation.
- Pulmonary hypertension: diagnostics and therapeutics.
- A spectrum of Pulmonary vascular pathology in portoPulmonary hypertension.
- HepatoPulmonary syndromes.
- Hepatic hydrothorax: pathogenesis, diagnosis, and management.
- Late recurrence and rapid evolution of severe hepatoPulmonary syndrome after liver transplantation.
- Inhaled nitric oxide reduces Pulmonary artery pressures in portoPulmonary hypertension.
- Progressive splenomegaly after epoprostenol therapy in portoPulmonary hypertension.
- Improvement in Pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portoPulmonary hypertension.
- Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.
- Use of macroaggregated albumin lung perfusion scan to diagnose hepatoPulmonary syndrome: a new approach.
- PortoPulmonary hypertension: the next step.
- Pathophysiology of arterial hypoxemia in advanced liver Disease.
- Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in Chronic liver disease.
- HepatoPulmonary syndrome versus portoPulmonary hypertension: distinctions and dilemmas.
- HepatoPulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review.
- Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, Chronic hepatitis C, and other hepatic problems.
- HepatoPulmonary syndrome. A Pulmonary vascular complication of liver disease.
- Frequency and clinical implications of increased Pulmonary artery pressures in liver transplant patients.
- Successful liver transplantation in patients with mild to moderate Pulmonary hypertension.
- HepatoPulmonary syndrome.
- Clinical management of hepatoPulmonary syndrome.
- HepatoPulmonary syndrome. Current concepts in diagnostic and therapeutic considerations.
- HepatoPulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue.
- Is severe arterial hypoxaemia due to hepatic Disease an indication for liver transplantation? A new therapeutic approach.
- Failure of hepatoPulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy.
- HepatoPulmonary syndrome: what are we learning from interventional radiology, liver transplantation, and other disorders?
- Admission data: their use in health planning, legislative presentations, and premedical programs.
- Azathioprine-associated Pulmonary dysfunction.
- Pulmonary aspects of Chronic liver disease and liver transplantation.
- Cardiac dysrhythmia following pneumonectomy. Clinical correlates and prognostic significance.
- Severe hypoxemia associated with liver Disease: Mayo Clinic experience and the experimental use of almitrine bismesylate.
- Effect of effort on measurement of forced expiratory volume in one second.
- Pulmonary aspects of liver disease and liver transplantation.
- Severe hypoxemia and liver Disease.
- A prospective study of airway reactivity before bone marrow transplantation.
- HepatoPulmonary syndrome: an evolving perspective in the era of liver transplantation.
- IntraPulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography.
Schools
University Of Nevada School Of Medicine
Evanston Hospital
Mayo Clinic Rochester
Conditions Treated
- Bronchiectasis
- Chronic Pulmonary Heart Diseases (incl. Pulmonary Hypertension)
- COPD (Chronic Obstructive Pulmonary Disease)
- Emphysema
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- America's Top Doctors
Education
-
Mayo School of Graduate Medical Education -
McGaw Medical Center of Northwestern University -
University of Nevada School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1588640528 | |
| NPPES Provider LastName | KROWKA | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 221.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588640528 |
| Last Name Of The Provider | KROWKA |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Joseph H. Skalski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Midthun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachele A. Gibson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan M. Dulohery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul D. Scanlon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Shepard Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay Kalra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Fontana, MD |
|
|
Dr. Mary E. Jones, MD |